• Christopher J Winterbottom, Rupal J Shah, Karen C Patterson, Maryl E Kreider, Reynold A Panettieri, Belinda Rivera-Lebron, Wallace T Miller, Leslie A Litzky, Trevor M Penning, Krista Heinlen, Tara Jackson, A Russell Localio, and Jason D Christie.
• Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, Yale University, New Haven, CT. Electronic address: christopher.winterbottom@yale.edu.
• Chest. 2018 May 1; 153 (5): 1221-1228.

BackgroundIdiopathic pulmonary fibrosis (IPF), a progressive disease with an unknown pathogenesis, may be due in part to an abnormal response to injurious stimuli by alveolar epithelial cells. Air pollution and particulate inhalation of matter evoke a wide variety of pulmonary and systemic inflammatory diseases. We therefore hypothesized that increased average ambient particulate matter (PM) concentrations would be associated with an accelerated rate of decline in FVC in IPF.MethodsWe identified a cohort of subjects seen at a single university referral center from 2007 to 2013. Average concentrations of particulate matter < 10 and < 2.5 μg/m3 (PM10 and PM2.5, respectively) were assigned to each patient based on geocoded residential addresses. A linear multivariable mixed-effects model determined the association between the rate of decline in FVC and average PM concentration, controlling for baseline FVC at first measurement and other covariates.ResultsOne hundred thirty-five subjects were included in the final analysis after exclusion of subjects missing repeated spirometry measurements and those for whom exposure data were not available. There was a significant association between PM10 levels and the rate of decline in FVC during the study period, with each μg/m3 increase in PM10 corresponding with an additional 46 cc/y decline in FVC (P = .008).ConclusionsAmbient air pollution, as measured by average PM10 concentration, is associated with an increase in the rate of decline of FVC in IPF, suggesting a potential mechanistic role for air pollution in the progression of disease.Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

20 keywords...

hide…